Name
bloods_fibrinactivity
Label
Fibrinogen Activity
Units
mg/dL
Type
numeric
Visit number vs Fibrinogen Activity
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 325.6 | ± 77.1 | 330.0 | -9.0 | 516.0 | - | 49 |
9-Month Followup | 43 | 319.8 | ± 82.2 | 321.0 | -9.0 | 560.0 | - | 43 |
18-Month Followup | 40 | 315.0 | ± 54.5 | 306.0 | 191.0 | 481.0 | - | 40 |
Randomized treatment arm vs Fibrinogen Activity
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 325.6 | ± 77.1 | 330.0 | -9.0 | 516.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 325.3 | ± 86.9 | 342.0 | -9.0 | 479.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 325.9 | ± 63.7 | 310.0 | 240.0 | 516.0 | - | 21 |
Randomized treatment arm vs Fibrinogen Activity
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 319.8 | ± 82.2 | 321.0 | -9.0 | 560.0 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 319.4 | ± 100.9 | 321.0 | -9.0 | 560.0 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 320.3 | ± 48.1 | 319.0 | 259.0 | 426.0 | - | 18 |
Randomized treatment arm vs Fibrinogen Activity
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 315.0 | ± 54.5 | 306.0 | 191.0 | 481.0 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 315.5 | ± 59.7 | 304.5 | 191.0 | 481.0 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 314.1 | ± 47.7 | 306.5 | 251.0 | 401.0 | - | 16 |
Age of the participant vs Fibrinogen Activity
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 325.6 | ± 77.1 | 330.0 | -9.0 | 516.0 | - | 49 |
27.0 to 45.0 years | 13 | 328.8 | ± 57.4 | 307.0 | 265.0 | 439.0 | - | 13 |
46.0 to 50.0 years | 12 | 317.4 | ± 34.3 | 328.0 | 233.0 | 362.0 | - | 12 |
51.0 to 56.0 years | 12 | 325.3 | ± 73.9 | 325.0 | 222.0 | 479.0 | - | 12 |
57.0 to 65.0 years | 12 | 330.4 | ± 124.8 | 352.0 | -9.0 | 516.0 | - | 12 |
Age of the participant vs Fibrinogen Activity
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 319.8 | ± 82.2 | 321.0 | -9.0 | 560.0 | - | 43 |
28.0 to 47.0 years | 11 | 305.5 | ± 27.5 | 315.0 | 268.0 | 340.0 | - | 11 |
47.0 to 52.0 years | 11 | 308.9 | ± 48.4 | 321.0 | 195.0 | 362.0 | - | 11 |
52.0 to 58.0 years | 11 | 313.3 | ± 144.6 | 318.0 | -9.0 | 560.0 | - | 11 |
58.0 to 65.0 years | 10 | 354.7 | ± 55.2 | 328.5 | 286.0 | 446.0 | - | 10 |
Age of the participant vs Fibrinogen Activity
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 315.0 | ± 54.5 | 306.0 | 191.0 | 481.0 | - | 40 |
29.0 to 46.0 years | 10 | 296.1 | ± 37.1 | 304.0 | 242.0 | 348.0 | - | 10 |
47.0 to 52.0 years | 10 | 296.4 | ± 46.4 | 302.0 | 191.0 | 362.0 | - | 10 |
53.0 to 58.0 years | 10 | 332.4 | ± 58.7 | 347.0 | 229.0 | 400.0 | - | 10 |
58.0 to 65.0 years | 10 | 334.9 | ± 66.1 | 304.5 | 272.0 | 481.0 | - | 10 |
Gender of the participant vs Fibrinogen Activity
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 325.6 | ± 77.1 | 330.0 | -9.0 | 516.0 | - | 49 |
Male | 28 | 328.6 | ± 63.7 | 326.5 | 222.0 | 516.0 | - | 28 |
Female | 21 | 321.5 | ± 93.6 | 330.0 | -9.0 | 479.0 | - | 21 |
Gender of the participant vs Fibrinogen Activity
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 319.8 | ± 82.2 | 321.0 | -9.0 | 560.0 | - | 43 |
Male | 25 | 302.8 | ± 93.4 | 313.0 | -9.0 | 560.0 | - | 25 |
Female | 18 | 343.4 | ± 58.0 | 338.5 | 203.0 | 446.0 | - | 18 |
Gender of the participant vs Fibrinogen Activity
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 315.0 | ± 54.5 | 306.0 | 191.0 | 481.0 | - | 40 |
Male | 25 | 301.6 | ± 48.8 | 302.0 | 191.0 | 400.0 | - | 25 |
Female | 15 | 337.3 | ± 57.9 | 325.0 | 265.0 | 481.0 | - | 15 |
Race of the participant vs Fibrinogen Activity
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 328.4 | ± 78.6 | 332.0 | -9.0 | 516.0 | - | 46 |
white | 35 | 330.7 | ± 85.6 | 336.0 | -9.0 | 516.0 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 312.0 | ± 39.3 | 315.0 | 240.0 | 362.0 | - | 9 |
asian | 2 | 363.0 | ± 107.5 | 363.0 | 287.0 | 439.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Fibrinogen Activity
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 321.6 | ± 84.9 | 321.0 | -9.0 | 560.0 | - | 40 |
white | 31 | 322.6 | ± 95.0 | 321.0 | -9.0 | 560.0 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 321.4 | ± 36.6 | 325.0 | 259.0 | 377.0 | - | 8 |
asian | 1 | 293.0 | - | 293.0 | 293.0 | 293.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Fibrinogen Activity
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 316.5 | ± 55.6 | 306.0 | 191.0 | 481.0 | - | 37 |
white | 29 | 314.8 | ± 52.3 | 306.0 | 191.0 | 401.0 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 319.4 | ± 74.7 | 306.0 | 265.0 | 481.0 | - | 7 |
asian | 1 | 348.0 | - | 348.0 | 348.0 | 348.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |